Treatment of Uterine Leiomyoma Research Progress

【作者】 李莉宋静慧

【Author】 LI-Li1,SONG Jing-hui2(1.Department of Postgraduate Student 2009,Inner Mongolia Medical College,Hohhot 010059 China;2.Department of Obstetrics and Gynecology,The Affiliated Hospital of Inner Mongolia Medical College,Hohhot 010059 China)

【机构】 内蒙古医学院内蒙古医学院附属医院妇产科

【摘要】 子宫肌瘤是一种妇科常见的良性肿瘤,迄今为止其病因及发病机制还不太明确,且无理想的治疗药物。一般认为子宫肌瘤的发生和雌激素的长期刺激有关,其家族性较明显。本文总结了近年来子宫肌瘤的发生与治疗的研究进展,分别从遗传基因、激素、生长因子及其它主要旁路等方面进行总述,并根据治疗方法的不同,进行分别论述,以期寻找出新的研究方法,为子宫肌瘤治疗药物的相关研究提供依据。

【Abstract】 Uterine leiomyoma is a common gynecological benign tumor,by far its etiology and pathogenesis are not clear,and no ideal treatment medicine.Is generally believed that the incidence of uterine leiomyoma and estrogen in chronically stimulated,its familial obviously.This paper summarizes the incidence of uterine leiomyoma and treatment research progress,separately from the genetic,hormones,growth factors and other main bypass and other aspects of the general,and according to the different treatment methods,were discussed,in order to find out the new method for the treatment of uterine leiomyoma,drug related studies provide a basis.

【关键词】 子宫肌瘤; 治疗;

【Key words】 Uterine Leiomyoma; Treatment;


  • 【下载频次】1805